Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.14 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.7 |